Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05711615 |
Title | Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
National Cancer Institute Developmental Therapeutics Clinic | RECRUITING | Bethesda | Maryland | 20892 | United States | Details |
Dana-Farber - Harvard Cancer Center LAO | RECRUITING | Boston | Massachusetts | 02115 | United States | Details |
Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
University of Michigan Comprehensive Cancer Center | SUSPENDED | Ann Arbor | Michigan | 48109 | United States | Details |
University of Pittsburgh Cancer Institute (UPCI) | RECRUITING | Pittsburgh | Pennsylvania | 15232 | United States | Details |
M D Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |